Tumor Ablation Market Trends and Growth Driver 2034
Global Tumor Ablation Market Size- By Technology, By Treatment, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Sep-2025 | Report ID: HLCA25276 | Pages: 1 - 269 | Formats*: |
| Category : Healthcare | |||
Global Tumor Ablation Market Introduction and Overview
According to SPER Market Research, the Global Tumor Ablation Market is estimated to reach USD 7.26 billion by 2034 with a CAGR of 14.05%.
The report includes an in-depth analysis of the Global Tumor Ablation Market, including market size and trends, product mix, Applications, and supplier analysis. The Global Tumor Ablation market was valued at USD 1.95 billion in 2024 and is projected to increase at a compound annual growth rate (CAGR) of XX% between 2025 and 2034. The tumor ablation market is growing due to the rising number of cancer cases and demand for safer treatments.
By Treatment Insights
The percutaneous ablation segment held the largest revenue share in 2024 due to benefits like faster recovery, minimal scarring, patient comfort, quick surgery time, and cost-efficiency. However, its growth may be limited by higher complication risks, especially in hospitals lacking skilled professionals. On the other hand, the laparoscopic ablation segment is expected to grow the fastest. Percutaneous ablation is not suitable for many patients because of tumor location and higher recurrence rates, particularly for tumors near sensitive organs like the gastrointestinal tract or heart. In such cases, laparoscopic ablation offers a minimally invasive yet more effective long-term treatment, driving its rising demand.
By Application Insights
The “other†segment, which includes cancers like bone metastasis and ENT cancer, held the largest market share in 2024. The availability of advanced treatment methods and the growing prevalence of various cancers support market growth. The lung cancer segment is expected to grow the fastest, driven by the rising global cases largely caused by tobacco smoking, the leading risk factor. Kidney cancer is also anticipated to see rapid growth, with effective treatment options like radiofrequency and microwave ablation used for small tumors and patients with specific conditions. Increased medical imaging is leading to more diagnoses, boosting demand for these treatment procedures.
Regional Insights
North America leads the tumor ablation market due to strong government healthcare support, high purchasing power, reimbursement availability, and increasing cancer cases. U.S. policies like the Affordable Care Act improve healthcare affordability and quality. Precision medicine initiatives also help tailor treatments. These factors boost market growth in the region.
Market Competitive Landscape
The tumor ablation market is led by major companies like Medtronic, Boston Scientific, and Johnson & Johnson, focusing on innovative and minimally invasive treatments. Emerging players are advancing non-invasive technologies to compete. Some key players are- AngioDynamics, Bioventus Inc (Misonix Inc), Boston Scientific Corporation, Chongqing Haifu Medical Technology Co, Ltd, EDAP TMS, HealthTronics, Inc, H.S. Hospital Service S.p.A, Johnson & Johnson Service Inc (Ethicon, Inc), Medtronic plc, and Mermaid Medical.
Recent Developments:
In August 2023, Bioventus Inc. (Misonix Inc) received U.S. FDA clearance for its neXus SonaStar Elite handpiece, designed for procedures including the removal of malignant and benign spinal and brain tumors.
In July 2023, EDAP TMS gained reimbursement approval in Switzerland for its use of high-intensity focused ultrasound (HIFU) to treat prostate cancer.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Technology, By Treatment, By Application |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | AngioDynamics, Bioventus Inc (Misonix Inc), Boston Scientific Corporation, Chongqing Haifu Medical Technology Co, Ltd, EDAP TMS, HealthTronics, Inc, H.S. Hospital Service S.p.A, Johnson & Johnson Service Inc (Ethicon, Inc), Medtronic plc, Mermaid Medical. |
Key Topics Covered in the Report
- Global Tumor Ablation Market Size (FY’2021-FY’2034)
- Overview of Global Tumor Ablation Market
- Segmentation of Global Tumor Ablation Market By Application (Kidney Cancer, Liver cancer, Breast cancer, Lung cancer, Prostate cancer, other cancer)
- Segmentation of Global Tumor Ablation Market By Treatment (Surgical ablation, Laparoscopic ablation, Percutaneous ablation)
- Segmentation of Global Tumor Ablation Market By Technology (Radiofrequency ablation, Microwave ablation, Cryoablation, Irreversible electroporation ablation, HIFU, Other ablation technologies)
- Statistical Snap of Global Tumor Ablation Market
- Expansion Analysis of Global Tumor Ablation Market
- Problems and Obstacles in Global Tumor Ablation Market
- Competitive Landscape in the Global Tumor Ablation Market
- Details on Current Investment in Global Tumor Ablation Market
- Competitive Analysis of Global Tumor Ablation Market
- Prominent Players in the Global Tumor Ablation Market
- SWOT Analysis of Global Tumor Ablation Market
- Global Tumor Ablation Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Tumor Ablation Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Tumor Ablation Market
7.Global Tumor Ablation Market, By Technology (USD Million) 2021-2034
7.1.Radiofrequency ablation7.2.Microwave ablation7.3.Cryoablation7.4.Irreversible electroporation ablation7.5.HIFU7.6.Other ablation technologies
8.Global Tumor Ablation Market, By Treatment (USD Million) 2021-2034
8.1.Surgical ablation8.2.Laparoscopic ablation8.3.Percutaneous ablation
9.Global Tumor Ablation Market, By Application (USD Million) 2021-2034
9.1.Kidney Cancer9.2.Liver cancer9.3.Breast cancer9.4.Lung cancer9.5.Prostate cancer9.6.Other cancer
10.Global Tumor Ablation Market, (USD Million) 2021-2034
10.1.Global Tumor Ablation Market Size and Market Share
11.Global Tumor Ablation Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1. AngioDynamics
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.Bioventus Inc. (Misonix Inc)
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.Boston Scientific Corporation
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.Chongqing Haifu Medical Technology Co., Ltd
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.EDAP TMS
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.HealthTronics, Inc
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.H.S. Hospital Service S.p.A
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.Johnson & Johnson Service Inc (Ethicon, Inc)
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.Medtronic plc
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.Mermaid Medical
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Tumor Ablation Market is projected to reach USD 7.26 billion by 2034, growing at a CAGR of 14.05% during the forecast period.
Tumor Ablation Market size from 2025. The Market is expected to reach USD 7.26 billion by 2034, at a CAGR of 14.05% during the forecast period.
Tumor Ablation Market CAGR of 14.05% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Tumor Ablation Market size is USD 7.26 billion from 2025 to 2034.
Tumor Ablation Market covered By Technology, By Treatment, By Application
The North America is anticipated to have the highest Market share in the Tumor Ablation Market.
AngioDynamics, Bioventus Inc (Misonix Inc), Boston Scientific Corporation, Chongqing Haifu Medical Technology Co, Ltd, EDAP TMS, HealthTronics, Inc, H.S. Hospital Service S.p.A, Johnson & Johnson Service Inc (Ethicon, Inc), Medtronic plc, Mermaid Medical.
The report includes an in-depth analysis of the Global Tumor Ablation Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
